tiprankstipranks
Revvity (RVTY)
NYSE:RVTY
US Market
Want to see RVTY full AI Analyst Report?

Revvity (RVTY) Stock Forecast & Price Target

559 Followers
See the Price Targets and Ratings of:

RVTY Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
3 Buy
8 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Revvity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RVTY Stock 12 Month Forecast

Average Price Target

$109.29
▼(-1.07% Downside)
Based on 11 Wall Street analysts offering 12 month price targets for Revvity in the last 3 months. The average price target is $109.29 with a high forecast of $130.00 and a low forecast of $90.00. The average price target represents a -1.07% change from the last price of $110.47.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"85":"$85","108":"$108","131":"$131","96.5":"$96.5","119.5":"$119.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":130,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$130.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":109.28571428571428,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$109.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[85,96.5,108,119.5,131],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,112.52,113.86461538461538,115.20923076923077,116.55384615384615,117.89846153846153,119.24307692307693,120.58769230769231,121.93230769230769,123.27692307692308,124.62153846153846,125.96615384615384,127.31076923076924,128.6553846153846,{"y":130,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,112.52,112.27120879120879,112.02241758241757,111.77362637362637,111.52483516483515,111.27604395604395,111.02725274725275,110.77846153846153,110.52967032967032,110.28087912087912,110.0320879120879,109.7832967032967,109.53450549450548,{"y":109.28571428571428,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,112.52,110.78769230769231,109.05538461538461,107.32307692307693,105.59076923076923,103.85846153846154,102.12615384615384,100.39384615384616,98.66153846153846,96.92923076923077,95.19692307692307,93.46461538461539,91.7323076923077,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":87.986,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.861,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.506,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.401,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.223,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.555,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.939,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.455,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.796,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.625,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.457,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.769,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.52,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$130.00Average Price Target$109.29Lowest Price Target$90.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on RVTY
Bernstein
Bernstein
$115
Hold
4.10%
Upside
Reiterated
07/22/26
Bernstein Sticks to Their Hold Rating for Revvity (RVTY)
Leerink Partners Analyst forecast on RVTY
Leerink Partners
Leerink Partners
Buy
Reiterated
07/17/26
Revvity (RVTY) Receives a Buy from Leerink Partners
TD Cowen
$120$130
Buy
17.68%
Upside
Reiterated
07/15/26
Revvity price target raised to $130 from $120 at TD CowenRevvity price target raised to $130 from $120 at TD Cowen
Evercore ISI Analyst forecast on RVTY
Evercore ISI
Evercore ISI
$110$125
Buy
13.15%
Upside
Reiterated
07/06/26
Revvity price target raised to $125 from $110 at Evercore ISIRevvity price target raised to $125 from $110 at Evercore ISI
Barclays Analyst forecast on RVTY
Barclays
Barclays
$105
Hold
-4.95%
Downside
Reiterated
06/24/26
Barclays Remains a Hold on Revvity (RVTY)
Wolfe Research Analyst forecast on RVTY
Wolfe Research
Wolfe Research
Hold
Initiated
06/01/26
Revvity assumed with a Peer Perform at Wolfe ResearchRevvity assumed with a Peer Perform at Wolfe Research
Bank of America Securities Analyst forecast on RVTY
Bank of America Securities
Bank of America Securities
Hold
Reiterated
05/14/26
Analysts Conflicted on These Healthcare Names: Cullinan Management (NASDAQ: CGEM), Humacyte (NASDAQ: HUMA) and Revvity (NYSE: RVTY)
Guggenheim Analyst forecast on RVTY
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
Hold
Reiterated
05/11/26
Revvity (RVTY) Receives a Hold from Guggenheim
Stifel Nicolaus Analyst forecast on RVTY
Stifel Nicolaus
Stifel Nicolaus
$110$100
Hold
-9.48%
Downside
Assigned
05/06/26
Revvity price target lowered to $100 from $110 at StifelRevvity price target lowered to $100 from $110 at Stifel
J.P. Morgan Analyst forecast on RVTY
J.P. Morgan
J.P. Morgan
$96$90
Hold
-18.53%
Downside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Option Care Health (NASDAQ: OPCH) and OnKure Therapeutics (NASDAQ: OKUR)
Goldman Sachs Analyst forecast on RVTY
Goldman Sachs
Goldman Sachs
$95$100
Hold
-9.48%
Downside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Vir Biotechnology (NASDAQ: VIR) and Johnson & Johnson (NYSE: JNJ)
Robert W. Baird
$129$117
Buy
5.91%
Upside
Reiterated
05/04/26
Revvity price target lowered to $125 from $129 at BairdRevvity price target lowered to $125 from $129 at Baird
Nephron
$90
Hold
-18.53%
Downside
Upgraded
03/26/26
Revvity upgraded to Hold from Sell at Nephron ResearchRevvity upgraded to Hold from Sell at Nephron Research
UBS Analyst forecast on RVTY
Unknown Analyst
UBS
Not Ranked
UBS
$115$120
Buy
8.63%
Upside
Reiterated
02/03/26
Revvity (RVTY) Receives a Buy from UBS
Wells Fargo
$107$110
Hold
-0.43%
Downside
Reiterated
02/03/26
Wells Fargo Reaffirms Their Hold Rating on Revvity (RVTY)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on RVTY
Bernstein
Bernstein
$115
Hold
4.10%
Upside
Reiterated
07/22/26
Bernstein Sticks to Their Hold Rating for Revvity (RVTY)
Leerink Partners Analyst forecast on RVTY
Leerink Partners
Leerink Partners
Buy
Reiterated
07/17/26
Revvity (RVTY) Receives a Buy from Leerink Partners
TD Cowen
$120$130
Buy
17.68%
Upside
Reiterated
07/15/26
Revvity price target raised to $130 from $120 at TD CowenRevvity price target raised to $130 from $120 at TD Cowen
Evercore ISI Analyst forecast on RVTY
Evercore ISI
Evercore ISI
$110$125
Buy
13.15%
Upside
Reiterated
07/06/26
Revvity price target raised to $125 from $110 at Evercore ISIRevvity price target raised to $125 from $110 at Evercore ISI
Barclays Analyst forecast on RVTY
Barclays
Barclays
$105
Hold
-4.95%
Downside
Reiterated
06/24/26
Barclays Remains a Hold on Revvity (RVTY)
Wolfe Research Analyst forecast on RVTY
Wolfe Research
Wolfe Research
Hold
Initiated
06/01/26
Revvity assumed with a Peer Perform at Wolfe ResearchRevvity assumed with a Peer Perform at Wolfe Research
Bank of America Securities Analyst forecast on RVTY
Bank of America Securities
Bank of America Securities
Hold
Reiterated
05/14/26
Analysts Conflicted on These Healthcare Names: Cullinan Management (NASDAQ: CGEM), Humacyte (NASDAQ: HUMA) and Revvity (NYSE: RVTY)
Guggenheim Analyst forecast on RVTY
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
Hold
Reiterated
05/11/26
Revvity (RVTY) Receives a Hold from Guggenheim
Stifel Nicolaus Analyst forecast on RVTY
Stifel Nicolaus
Stifel Nicolaus
$110$100
Hold
-9.48%
Downside
Assigned
05/06/26
Revvity price target lowered to $100 from $110 at StifelRevvity price target lowered to $100 from $110 at Stifel
J.P. Morgan Analyst forecast on RVTY
J.P. Morgan
J.P. Morgan
$96$90
Hold
-18.53%
Downside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Option Care Health (NASDAQ: OPCH) and OnKure Therapeutics (NASDAQ: OKUR)
Goldman Sachs Analyst forecast on RVTY
Goldman Sachs
Goldman Sachs
$95$100
Hold
-9.48%
Downside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Vir Biotechnology (NASDAQ: VIR) and Johnson & Johnson (NYSE: JNJ)
Robert W. Baird
$129$117
Buy
5.91%
Upside
Reiterated
05/04/26
Revvity price target lowered to $125 from $129 at BairdRevvity price target lowered to $125 from $129 at Baird
Nephron
$90
Hold
-18.53%
Downside
Upgraded
03/26/26
Revvity upgraded to Hold from Sell at Nephron ResearchRevvity upgraded to Hold from Sell at Nephron Research
UBS Analyst forecast on RVTY
Unknown Analyst
UBS
Not Ranked
UBS
$115$120
Buy
8.63%
Upside
Reiterated
02/03/26
Revvity (RVTY) Receives a Buy from UBS
Wells Fargo
$107$110
Hold
-0.43%
Downside
Reiterated
02/03/26
Wells Fargo Reaffirms Their Hold Rating on Revvity (RVTY)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Revvity

3 Months
Success Rate
24/37 ratings generated profit
65%
Average Return
+3.09%
Copying Catherine Ramsey Schulte's trades and holding each position for 3 Months would result in 64.86% of your transactions generating a profit, with an average return of +3.09% per trade.
1 Year
Success Rate
10/15 ratings generated profit
67%
Average Return
+5.64%
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +5.64% per trade.
2 Years
Success Rate
11/15 ratings generated profit
73%
Average Return
+6.83%
Copying Daniel Brennan's trades and holding each position for 2 Years would result in 73.33% of your transactions generating a profit, with an average return of +6.83% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RVTY Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
6
3
4
6
4
Hold
10
11
11
10
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
14
15
16
8
In the current month, RVTY has received 4 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. RVTY average Analyst price target in the past 3 months is 109.29.
Each month's total comprises the sum of three months' worth of ratings.

RVTY Financial Forecast

RVTY Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

RVTY Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

RVTY Stock Forecast FAQ

What is RVTY’s average 12-month price target, according to analysts?
Based on analyst ratings, Revvity’s 12-month average price target is 109.29.
    What is RVTY’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for RVTY, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is RVTY a Buy, Sell or Hold?
        Revvity has a consensus rating of Moderate Buy which is based on 3 buy ratings, 8 hold ratings and 0 sell ratings.
          What is Revvity’s price target?
          The average price target for Revvity is 109.29. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $130.00 ,the lowest forecast is $90.00. The average price target represents -1.07% Decrease from the current price of $110.47.
            What do analysts say about Revvity?
            Revvity’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
              How can I buy shares of RVTY?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.